Persistent infection of the uterine cervix with high-risk human papillomaviruses (HPV) is causally associated with cancer of the cervix. A few studies have reported the presence of HPV DNA in the blood of women with cervical neoplasia. The aim of this study was to determine if HPV DNA could be detec
HPV and cervical cancer
✍ Scribed by Jan Pontén; Hans-Olov Adami; Lars-Gösta Friberg; Leif Gustafsson; Anthony B. Miller; Max Parkin; Pär Sparén; Dimitrios Trichopoulous
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 103 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Human papillomavirus (HPV) is the central etiologic factor for cervical cancer, and prior studies suggested __C. trachomatis__ may act as an HPV cofactor. We examined the __C. trachomatis__‐cervical cancer association by serotype, histology, HPV type in the tumor, and other HPV cofactor
Extensive experimental and limited epidemiologic data suggest that adeno-associated viruses (AAV) can have antioncogenic activity and may be protective factors for the development of cervical cancer. To examine the association between AAV-2 IgG antibodies and cervical neoplasia in Spain and Colombia
Cervical cancer is the second most common cancer among Tunisian women, and the incidence rates vary by region. Three Tunisian registries report age-standardized rates of 6.3/ 10 5 in the central region, 5.4/10 5 in the north, and 2.7/10 5 in the south. High-risk human papillomavirus (HPV) types and